HEADER TRANSFERASE 15-AUG-14 4UWZ OBSLTE 18-MAR-15 4UWZ 5AM6 TITLE NATIVE FGFR1 WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 458-765; COMPND 5 SYNONYM: FGFR-1, FIBROBLAST GROWTH FACTOR 1, BASIC FIBROBLAST COMPND 6 GROWTH FACTOR RECEPTOR FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, COMPND 7 PROTO-ONCOGENE C-FGR, CD331; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41 LAMBDA 37; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PJ821 KEYWDS TRANSFERASE, FGFR1, DRUG, CANCER, FGF, RECEPTORS, GROWTH FACTORS, KEYWDS 2 SIGNALLING, ENZYME EXPDTA X-RAY DIFFRACTION AUTHOR N.THIYAGARAJAN,T.BUNNEY,M.KATAN REVDAT 2 18-MAR-15 4UWZ 1 OBSLTE REVDAT 1 25-FEB-15 4UWZ 0 JRNL AUTH T.BUNNEY,S.WAN,N.THIYAGARAJAN,L.SUTTO,S.V.WILLIAMS, JRNL AUTH 2 P.ASHFORD,H.KOSS,M.A.KNOWLES,F.L.GERVASIO,P.V.COVENEY, JRNL AUTH 3 M.KATAN JRNL TITL THE EFFECT OF MUTATIONS ON DRUG SENSITIVITY AND KINASE JRNL TITL 2 ACTIVITY OF FIBROBLAST GROWTH FACTOR RECEPTORS: A COMBINED JRNL TITL 3 EXPERIMENTAL AND THEORETICAL STUDY JRNL REF EBIOMEDICINE 2015 JRNL REFN ESSN 2352-3964 JRNL DOI 10.1016/J.EBIOM.2015.02.009 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU, REMARK 3 STEINER,NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 95.67 REMARK 3 NUMBER OF REFLECTIONS : 48863 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.21550 REMARK 3 R VALUE (WORKING SET) : 0.21360 REMARK 3 FREE R VALUE : 0.25262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.8 REMARK 3 FREE R VALUE TEST SET COUNT : 2475 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.960 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.011 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3583 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.324 REMARK 3 BIN FREE R VALUE SET COUNT : 182 REMARK 3 BIN FREE R VALUE : 0.339 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4560 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 256 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.024 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.88 REMARK 3 B22 (A**2) : 3.85 REMARK 3 B33 (A**2) : -0.71 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : -0.19 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.177 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.162 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.878 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4732 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4626 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6399 ; 1.182 ; 1.997 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10696 ; 0.723 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 572 ; 5.420 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 206 ;35.948 ;24.126 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 862 ;13.744 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 33 ;16.478 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 719 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5158 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 995 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2300 ; 2.206 ; 4.298 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2299 ; 2.206 ; 4.296 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2865 ; 3.584 ; 6.418 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2866 ; 3.584 ; 6.420 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2432 ; 2.434 ; 4.667 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2433 ; 2.434 ; 4.668 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3534 ; 4.119 ; 6.849 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5348 ; 6.627 ;33.957 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5290 ; 6.599 ;33.859 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4UWZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-AUG-14. REMARK 100 THE PDBE ID CODE IS EBI-61544. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS 6M) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51344 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.96 REMARK 200 RESOLUTION RANGE LOW (A) : 43.26 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 4.5 REMARK 200 R MERGE (I) : 0.07 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.2 REMARK 200 R MERGE FOR SHELL (I) : 0.48 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.60 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 5K MME, 0.1 M TRIS, REMARK 280 PH 7.5, 0.2 M (NH4)2SO4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.33500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.79500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.33500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.79500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 456 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 MET B 456 REMARK 465 VAL B 457 REMARK 465 ALA B 458 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 ASP B 652 REMARK 465 TYR B 653 REMARK 465 TYR B 654 REMARK 465 LYS B 655 REMARK 465 LYS B 656 REMARK 465 THR B 657 REMARK 465 THR B 658 REMARK 465 ASN B 659 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 646 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 596 OD1 ASN A 763 2.09 REMARK 500 O GLY B 459 O HOH B 2001 1.20 REMARK 500 O VAL B 460 O HOH B 2002 1.76 REMARK 500 OE2 GLU B 462 O HOH B 2003 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 458 -112.98 60.17 REMARK 500 LYS A 504 75.97 -113.52 REMARK 500 ARG A 622 -16.63 84.12 REMARK 500 GLN A 764 -64.35 78.79 REMARK 500 ALA B 488 -58.26 63.53 REMARK 500 GLU B 592 40.87 -151.65 REMARK 500 GLN B 594 -154.85 -141.26 REMARK 500 SER B 597 -56.90 64.38 REMARK 500 ARG B 622 -21.70 80.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DOV A1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DOV B1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1766 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1767 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UWY RELATED DB: PDB REMARK 900 FGFR1 APO STRUCTURE REMARK 900 RELATED ID: 4UX0 RELATED DB: PDB REMARK 900 FGFR1 MUTANT WITH AN INHIBITOR DBREF 4UWZ A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4UWZ B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4UWZ MET A 456 UNP P11362 EXPRESSION TAG SEQADV 4UWZ VAL A 457 UNP P11362 EXPRESSION TAG SEQADV 4UWZ ALA A 488 UNP P11362 CYS 488 CONFLICT SEQADV 4UWZ SER A 584 UNP P11362 CYS 584 CONFLICT SEQADV 4UWZ MET B 456 UNP P11362 EXPRESSION TAG SEQADV 4UWZ VAL B 457 UNP P11362 EXPRESSION TAG SEQADV 4UWZ ALA B 488 UNP P11362 CYS 488 CONFLICT SEQADV 4UWZ SER B 584 UNP P11362 CYS 584 CONFLICT SEQRES 1 A 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 A 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 A 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 A 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 A 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 A 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 A 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 A 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 A 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 A 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 A 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 A 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 A 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 A 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 A 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 A 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 A 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 A 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 A 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 A 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 A 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 A 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 A 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 A 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 B 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 B 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 B 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 B 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 B 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 B 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 B 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 B 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 B 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 B 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 B 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 B 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 B 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 B 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 B 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 B 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 B 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 B 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 B 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 B 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 B 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 B 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 B 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET DOV A1000 29 HET DOV B1000 29 HET CL A1766 1 HET CL A1767 1 HET CL A1768 1 HETNAM CL CHLORIDE ION HETNAM DOV 1-AMINO-5-FLUORO-3-(6-(4-METHYLPIPERAZIN-1- HETNAM 2 DOV YL)-1H-BENZO[D]IMIDAZOL-2-YL)QUINOLIN-2(1H)- HETNAM 3 DOV ONE FORMUL 3 CL 3(CL 1-) FORMUL 4 DOV 2(C21 H37 F N6 O) FORMUL 5 HOH *256(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ALA A 575 1 8 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 LEU A 662 MET A 667 5 6 HELIX 7 7 ALA A 668 ARG A 675 1 8 HELIX 8 8 THR A 678 THR A 695 1 18 HELIX 9 9 PRO A 705 GLU A 715 1 11 HELIX 10 10 THR A 726 TRP A 737 1 12 HELIX 11 11 VAL A 740 ARG A 744 5 5 HELIX 12 12 THR A 746 THR A 761 1 16 HELIX 13 13 PRO B 474 ASP B 476 5 3 HELIX 14 14 THR B 521 GLY B 539 1 19 HELIX 15 15 ASN B 568 ALA B 575 1 8 HELIX 16 16 SER B 597 LYS B 617 1 21 HELIX 17 17 ALA B 625 ARG B 627 5 3 HELIX 18 18 LEU B 662 MET B 667 5 6 HELIX 19 19 ALA B 668 ASP B 674 1 7 HELIX 20 20 THR B 678 THR B 695 1 18 HELIX 21 21 PRO B 705 GLU B 715 1 11 HELIX 22 22 THR B 726 TRP B 737 1 12 HELIX 23 23 VAL B 740 ARG B 744 5 5 HELIX 24 24 THR B 746 LEU B 760 1 15 SHEET 1 AA 5 LEU A 478 GLY A 485 0 SHEET 2 AA 5 GLN A 491 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 AA 5 VAL A 508 MET A 515 -1 O THR A 509 N ALA A 497 SHEET 4 AA 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514 SHEET 5 AA 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AB 2 VAL A 629 VAL A 631 0 SHEET 2 AB 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 BA 5 LEU B 478 GLU B 486 0 SHEET 2 BA 5 GLN B 491 ILE B 498 -1 O VAL B 492 N LEU B 484 SHEET 3 BA 5 VAL B 508 MET B 515 -1 O THR B 509 N ALA B 497 SHEET 4 BA 5 TYR B 558 GLU B 562 -1 O VAL B 559 N LYS B 514 SHEET 5 BA 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 BB 2 VAL B 629 VAL B 631 0 SHEET 2 BB 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 8 VAL A 561 GLU A 562 TYR A 563 ALA A 564 SITE 2 AC1 8 SER A 565 GLY A 567 LEU A 630 HOH A2158 SITE 1 AC2 9 ILE B 545 VAL B 561 GLU B 562 TYR B 563 SITE 2 AC2 9 ALA B 564 SER B 565 GLY B 567 LEU B 630 SITE 3 AC2 9 ASP B 641 SITE 1 AC3 3 ARG A 627 ARG A 661 HOH A2086 SITE 1 AC4 1 LYS A 618 CRYST1 208.670 57.590 65.560 90.00 107.39 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004792 0.000000 0.001501 0.00000 SCALE2 0.000000 0.017364 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015984 0.00000